Products

Medicines we make, manufacture and distribute

Prescribing information varies by country. The products below are marketed by Exxopharm and its distribution partners; availability depends on local approval.

Metabolic health

Exvelda

semaglenatide injection

Once-weekly incretin analogue for adults with type 2 diabetes and weight management.

Pre-filled pen, 0.5 / 1.0 / 2.0 mg

Loravyn

dapaglizide tablets

Oral glucose-lowering therapy used alone or with metformin.

Film-coated tablet, 5 / 10 mg

Rare disease

Fabrazyx

agalsidase exx

Enzyme replacement therapy for confirmed Fabry disease.

IV infusion, 35 mg vial

Hemtiva

coagulation factor exx

Extended half-life factor therapy for haemophilia A.

Lyophilised powder, 500 IU

Immunology

Nyvora

elostamab

Selective interleukin modulator for moderate to severe plaque psoriasis.

Auto-injector, 150 mg

Renuvia

belicortan

Maintenance therapy for adults with lupus nephritis.

Capsule, 20 mg

Manufacturing & distribution

We operate GMP-certified manufacturing in Kalundborg and Basel, with cold-chain distribution to more than 60 markets. Wholesalers, pharmacies and health systems can request supply agreements through our commercial team.